These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 1316068

  • 1. Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function.
    Nilsen OG, Saltvedt E, Walstad RA, Marstein S.
    Am J Med; 1992 Apr 06; 92(4A):38S-40S. PubMed ID: 1316068
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of lomefloxacin in renally compromised patients.
    Blum RA, Schultz RW, Schentag JJ.
    Antimicrob Agents Chemother; 1990 Dec 06; 34(12):2364-8. PubMed ID: 2088191
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of lomefloxacin in patients with cirrhosis.
    Lebrec D, Gaudin C, Benhamou JP.
    Am J Med; 1992 Apr 06; 92(4A):41S-44S. PubMed ID: 1316069
    [Abstract] [Full Text] [Related]

  • 4. Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Leroy A, Fillastre JP, Humbert G.
    Antimicrob Agents Chemother; 1990 Jan 06; 34(1):17-20. PubMed ID: 2327756
    [Abstract] [Full Text] [Related]

  • 5. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA.
    Am J Med; 1992 Apr 06; 92(4A):18S-21S. PubMed ID: 1316065
    [Abstract] [Full Text] [Related]

  • 6. Effect of renal impairment on the pharmacokinetics of grepafloxacin.
    Efthymiopoulos C, Bramer SL, Maroli A, Gambertoglio JG.
    Clin Pharmacokinet; 1997 Apr 06; 33 Suppl 1():32-8. PubMed ID: 9433654
    [Abstract] [Full Text] [Related]

  • 7. Quinolone pharmacokinetics in the elderly.
    Schentag JJ, Goss TF.
    Am J Med; 1992 Apr 06; 92(4A):33S-37S. PubMed ID: 1316067
    [Abstract] [Full Text] [Related]

  • 8. Renal clearance of lomefloxacin is decreased by furosemide.
    Sudoh T, Fujimura A, Shiga T, Sasaki M, Harada K, Tateishi T, Ohashi K, Ebihara A.
    Eur J Clin Pharmacol; 1994 Apr 06; 46(3):267-9. PubMed ID: 8070509
    [Abstract] [Full Text] [Related]

  • 9. The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.
    Wijnands GJ, Cornel JH, Martea M, Vree TB.
    Chest; 1990 Dec 06; 98(6):1440-4. PubMed ID: 2245687
    [Abstract] [Full Text] [Related]

  • 10. Lomefloxacin clinical pharmacokinetics.
    Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH.
    Clin Pharmacokinet; 1993 Jul 06; 25(1):6-19. PubMed ID: 8394795
    [Abstract] [Full Text] [Related]

  • 11. Effect of ranitidine on renal clearance of lomefloxacin.
    Sudoh T, Fujimura A, Harada K, Sunaga K, Ohmori M, Sakamoto K.
    Eur J Clin Pharmacol; 1996 Jul 06; 51(1):95-8. PubMed ID: 8880059
    [Abstract] [Full Text] [Related]

  • 12. Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
    Kovarik JM, Hoepelman AI, Smit JM, Sips PA, Rozenberg-Arska M, Glerum JH, Verhoef J.
    Antimicrob Agents Chemother; 1992 Nov 06; 36(11):2458-61. PubMed ID: 1336948
    [Abstract] [Full Text] [Related]

  • 13. Multiple-dose pharmacokinetics of rufloxacin in patients with cirrhosis.
    Triger DR, Granai F, Woodcock J, Wise R, Imbimbo BP.
    Hepatology; 1993 Oct 06; 18(4):847-52. PubMed ID: 8406358
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment.
    Boike SC, Pue MA, Freed MI, Audet PR, Fairless A, Ilson BE, Zariffa N, Jorkasky DK.
    Clin Pharmacol Ther; 1994 Apr 06; 55(4):418-26. PubMed ID: 8162668
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of temafloxacin in patients with liver impairment.
    Granneman GR, Mahr G, Locke C, Nickel P, Kirch W, Fabian W, Kinzig M, Naber KG, Sörgel F.
    Clin Pharmacokinet; 1992 Apr 06; 22 Suppl 1():24-32. PubMed ID: 1319868
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of sparfloxacin in patients with renal impairment.
    Dorr MB, Johnson RD, Jensen B, Magner D, Marbury T, Talbot GH.
    Clin Ther; 1999 Jul 06; 21(7):1202-15. PubMed ID: 10463518
    [Abstract] [Full Text] [Related]

  • 17. Temafloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Granneman GR, Braeckman R, Kraut J, Shupien S, Craft JC.
    Antimicrob Agents Chemother; 1991 Nov 06; 35(11):2345-51. PubMed ID: 1666497
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of sparfloxacin in patients with renal impairment.
    Fillastre JP, Montay G, Bruno R, Etienne I, Dhib M, Vivier N, Le Roux Y, Guimart C, Gay G, Schott D.
    Antimicrob Agents Chemother; 1994 Apr 06; 38(4):733-7. PubMed ID: 8031038
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.
    Morrison PJ, Mant TG, Norman GT, Robinson J, Kunka RL.
    Antimicrob Agents Chemother; 1988 Oct 06; 32(10):1503-7. PubMed ID: 3214495
    [Abstract] [Full Text] [Related]

  • 20. Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day dosing.
    Mant TG.
    Am J Med; 1992 Apr 06; 92(4A):26S-32S. PubMed ID: 1316066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.